Supplemental figure 2 from Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers
Year: 2023
Type: supplementary-materials
Abstract: MEHD7945A was more effective than anti-EGFR or anti-HER3 antibody in inhibiting cell signaling, cell proliferation and clonogenity.
Authors: Chunrong Li, Shyhmin Huang, Eric A. Armstrong, David M. Francis, Lauryn R. Werner, Mark X. Sliwkowski, Albert van der Kogel, Paul M. Harari
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362623271